BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11156698)

  • 1. Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture.
    Hokama S; Toma C; Jahana M; Iwanaga M; Morozumi M; Hatano T; Ogawa Y
    Mol Urol; 2000; 4(4):321-8. PubMed ID: 11156698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate.
    Chalmers AH; Cowley DM; McWhinney BC
    Clin Chem; 1985 Oct; 31(10):1703-5. PubMed ID: 3930094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of polymerase chain reaction to detect Proteus mirabilis and Ureaplasma urealyticum in urinary calculi.
    Huang HS; Chen J; Teng LJ; Lai MK
    J Formos Med Assoc; 1999 Dec; 98(12):844-50. PubMed ID: 10634025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial degradation of dietary oxalate in the human gut and urinary oxalate concentrations in patients with calcium oxalate urolithiasis and control persons.
    Kleinschmidt K; Mahlmann A; Hautmann R
    Investig Urol (Berl); 1994; 5():222-4. PubMed ID: 7719310
    [No Abstract]   [Full Text] [Related]  

  • 6. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible etiological role for ascorbate in calculi formation.
    Chalmers AH; Cowley DM; Brown JM
    Clin Chem; 1986 Feb; 32(2):333-6. PubMed ID: 3943193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic studies during urinary diversion by way of the small intestine].
    Schneider HJ; Bockhorn V
    Z Urol Nephrol; 1979 May; 72(5):365-74. PubMed ID: 39393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
    Oehlschläger S; Fuessel S; Meye A; Herrmann J; Froehner M; Albrecht S; Wirth MP
    Urology; 2009 Mar; 73(3):480-3. PubMed ID: 19167040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrolithiasis in patients with intestinal diseases].
    Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
    G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A modification of the estimation of urinary oxalate using a Sigma kit].
    Ebisuno S; Ohkawa T
    Hinyokika Kiyo; 1988 Feb; 34(2):225-30. PubMed ID: 3376811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of nutritional supplements and monosaccharides on growth, oxalate accumulation, and culture pH by Sclerotinia sclerotiorum.
    Culbertson BJ; Furumo NC; Daniel SL
    FEMS Microbiol Lett; 2007 May; 270(1):132-8. PubMed ID: 17355598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high dose vitamin C on urinary oxalate levels.
    Wandzilak TR; D'Andre SD; Davis PA; Williams HE
    J Urol; 1994 Apr; 151(4):834-7. PubMed ID: 8126804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of infection in urinary calculosis. Lithogenic effect in vitro of a Proteus mirabilis strain].
    Fontana G; Savoia D; Martinetto P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):352-61. PubMed ID: 4949683
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical evaluation of a commercial enzyme kit (Sigma) for determining oxalate concentrations in urine.
    Parkinson IS; Sheldon WL; Laker MF; Smith PA
    Clin Chem; 1987 Jul; 33(7):1203-7. PubMed ID: 3594848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.
    Dhar NB; Grundfest S; Jones JS; Streem SB
    J Urol; 2005 Nov; 174(5):1844-6; discussion 1846. PubMed ID: 16217311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of urinary oxalate by ion chromatography: some modifications.
    Ogawa Y; Kitagawa R
    Hinyokika Kiyo; 1984 Feb; 30(2):147-52. PubMed ID: 6377856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary necrosis in vitro: a scanning electron microscopic comparison of escherichia coli and Proteus mirabilis infection.
    Cohen MS; Davis CP; Baur PS; Warren MM
    Scan Electron Microsc; 1981; (Pt 3):65-72. PubMed ID: 7036330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.